Clinical Trials in Los Angeles

Showing 14421-14440 of 16,901 trials

Citalopram for Agitation in Alzheimer's Disease

NCT00898807

The purpose of this study is to evaluate the safety and efficacy of citalopram for agitation in Alzheimer's dementia.

JHSPH Center for Clinical Trials186 participantsStarted Jul 2009

Los Angeles, California, United States • Palo Alto, California, United States • Baltimore, Maryland, United States +5 more locations

COMPLETEDPhase 3< 1 mile

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

NCT00113607

The purpose of the study is to compare the progression-free survival (PFS) of the combination of trabectedin + DOXIL with DOXIL monotherapy in patients with ovarian cancer.

Ovarian Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.672 participantsStarted Apr 2005

Mobile, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +108 more locations

Citalopram for Agitation in Alzheimer's Disease

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Find Trials by Condition in Los Angeles

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes

Dose Range Finding Study of Fedovapagon in Men With Nocturia

Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

AST-120 Used to Treat Mild Hepatic Encephalopathy

Ondansetron and the QT Interval In Adult Emergency Department Patients

Effects of School Gardens on Children's Diet, Nutritional Knowledge, Etc.

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I